Fayez Sarofim, a billionaire darling of Houston high society known for running a Texas investment company, has agreed to pay a $720,000 civil penalty for failing to report the purchase of voting securities of Kinder Morgan and Kemper Corporation, the Federal Trade Commission said on Friday.
Sarofim, chairman of Fayez Sarofim & Co investment advisers, bought Kinder Morgan securities in 2001, 2006 and 2012, and Kemper Corp securities in 2007 but failed to notify antitrust enforcers, the FTC said.
Big mergers and large share purchases must be reported to the Federal Trade Commission, which works with the Justice Department to ensure that the transactions are legal under antitrust law.
The Egyptian-born, thrice-married Sarofim, whose life story rivals anything seen in TV soap operas, supported Jeb Bush in his run for the presidency.
He is one of 20 “investment professionals” listed on the web site of his Houston-based firm, Fayez Sarofim & Co.
Full Content: Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas